‹ ›
MYP_171727
← PREVIOUS NEXT → BACK
Basic Information
Pepstatin A
Antimicrobial
Antiparasitic ▸ Antimalarial
Antiparasitic ▸ General antiparasitic ▸ Antiparasitic
not Standard
5 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
VVXAX
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0008859 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protease/Proteasome inhibitor
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
None
None
Isovaleryl, sta=statin
Bio-Activity Profile
Antimicrobial Antiparasitic Antimalarial
Plasmodium falciparum Dd2
25.0±3.0 μM
IC50; [3H] Hypoxanthine incorporation assay
PaperRole of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors PMID19752273 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/19752273/
RECORD: Rec_0138199 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protease/Proteasome inhibitor
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
None
None
Isovaleryl, sta=statin
Bio-Activity Profile
Antimicrobial Antiparasitic Antimalarial
Plasmodium falciparum Δpfpm4 parasite line
23.4±2.6 μM
IC50; [3H] Hypoxanthine incorporation assay
PaperRole of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors PMID19752273 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/19752273/
RECORD: Rec_0195089 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protease/Proteasome inhibitor
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
None
None
Isovaleryl, sta=statin
Bio-Activity Profile
Antimicrobial Antiparasitic Antimalarial
Plasmodium falciparum Δpfpm1 parasite line
27.5±2.1 μM
IC50; [3H] Hypoxanthine incorporation assay
PaperRole of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors PMID19752273 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/19752273/
RECORD: Rec_0201768 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protease/Proteasome inhibitor
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
None
None
Isovaleryl, sta=statin
Bio-Activity Profile
Antimicrobial Antiparasitic Antimalarial
Plasmodium falciparum Δpfpm2 parasite line
23.5±1.3 μM
IC50; [3H] Hypoxanthine incorporation assay
PaperRole of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors PMID19752273 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/19752273/
RECORD: Rec_0218617 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protease/Proteasome inhibitor
32630
Structure & Mods
linear peptide [Linear]
noncanonical stereochemical modification [Modified]
None
None
Isovaleryl, sta=statin
Bio-Activity Profile
Antimicrobial Antiparasitic Antimalarial
Plasmodium falciparum GC03 parasite line
36.0±2.8 μM
IC50; [3H] Hypoxanthine incorporation assay
PaperRole of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors PMID19752273 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/19752273/
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2